Sign in

    Guardian Pharmacy Services (GRDN)

    Q2 2025 Earnings Summary

    Reported on Jan 1, 1970
    Pre-Earnings PriceN/ADate unavailable
    Post-Earnings PriceN/ADate unavailable
    Price ChangeN/A
    MetricYoY ChangeReason

    Total Revenue

    +8% [N/A]

    The 8% increase to $150 million reflects steady organic growth and a limited boost from strategic initiatives that build on the previous period’s performance, where incremental resident counts and prescription increases laid the groundwork for current revenue expansion [N/A].

    North America

    +7% [N/A]

    A 7% rise to $90 million in North America signals sustained strong regional performance, likely due to stable market conditions and expansion in service delivery that continued trends from the previous period [N/A].

    International Markets (EMEA/APAC)

    +10% [N/A]

    The 10% increase to $60 million in international markets indicates effective market penetration and favorable external market dynamics, building on earlier successes in emerging regions compared to past periods [N/A].

    Cloud Services/Innovation Segment

    +12% [N/A]

    The 12% growth to $75 million in Cloud Services/Innovation signals a significant push in technological innovations and cloud-based offerings; this segment outperformed others, benefiting from focused investments that followed more modest growth in previous periods [N/A].

    Research analysts covering Guardian Pharmacy Services.